Onsat 8 Oral Soluble Film

Chemotherapy-Induced Nausea and Vomiting-Adults, Pediatric Patients (6 Months to 18 Years): 8 mg Tabletlet/Orodispersible Tabletlet: Three 0.15 mg/kg Doses, Up to a Maximum of 16 mg Per Dose.
4 mg Orodispersible Tabletlet: Three 0.15 mg/kg Doses, Up to a Maximum of 16 mg Per Dose.
Injection: Three 0.15 mg/kg Doses, Up to a Maximum of 16 mg Per Dose, Infused Intravenously over 15 Minutes.
Radiotherapy-Induced Nausea and Vomiting-Adults: 8 mg Tabletlet/Orodispersible Tabletlet: Initial Dose: 8 mg Orally 1 to 2 Hours Before Radiotherapy. Post Radiotherapy: 8 mg Orally Every 8 Hours for Up to 5 Days After a Course of Treatment.
4 mg Orodispersible Tabletlet: Three 0.15 mg/kg Doses, Up to a Maximum of 16 mg Per Fose.
Injection: Three 0.15 mg/kg Doses, Up to a Maximum of 16 mg Per Dose, Infused Intravenously Over 15 Minutes.
Postoperative Nausea and Vomiting- Adults: 8 mg Tabletlet/Orodispersible Tabletlet: 16 mg Given as Two 8 mg Tabletlets 4 mg Orodispersible Tabletlet: 16 mg
Injection: 4 mg Pediatrics (>40 kg): Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg